Drug/Important Bio-Agent (IBA)
Index
- 1(
1((2-(4-chlorophenyl)cyclopropyl)methoxy)-3,4-dihydroxy-5-((3-(4-hydroxyphenyl)-1-oxo-2-propenyl)oxy)-cyclohexanecarboxylic acid
1(2H)-Isoquinolinone, 3,4-dihydro-5-methyl-
1(2H)-Isoquinolinone, 4-(2-hydroxy-3-((2-(2-methoxyphenoxy)-1-methylethyl)amino)propoxy)-
1(2H)-Isoquinolinone, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-2-methyl-
1(2H)-naphthalenone, 3,4-dihydro-2-(((2-(4-hydroxyphenyl)ethyl)amino)methyl)-
1(2H)-Naphthalenone, 3,4-dihydro-3,6,8-trihydroxy-, (S)-
1(2H)-Naphthalenone, 3,4-dihydro-3,8-dihydroxy-
1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, (S)-
1(2H)-phthalazinone
1(2H)-phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone
1(2H)-Phthalazinone, hydrazone
1(2H)-Pyridinepropanenitrile, 3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-
1(2H)-Pyrimidineacetic acid, 5-((1-(carboxymethyl)hexahydro-2,4,6-trioxo-5-pyrimidinyl)imino)tetrahydro-2,4,6-trioxo-
1(2H)-Pyrimidinecarboxamide, 5-fluoro-3,4-dihydro-N-(5-hydroxyhexyl)-2,4-dioxo-
1(2H)-pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-
1(2H)-Quinoxalinecarboxylic acid, 7-chloro-3,4-dihydro-2,2-dimethyl-3-thioxo-, 1-methylethenyl ester
1(3),2-diacylglyceryl-3(1)-O-4'-(N,N,N-trimethyl)homoserine
1(3aH)-Cyclopentacyclopentadecenone, 4,7,8,9,12,13,16,16a-octahydro-2,7-dihydroxy-3-(2-hydroxy-1-methylethyl)-6,10,14,16a-tetramethyl-, (3aR-(3(S*),3aR*,5E,7S*,10E,14E,16aS*))-
1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxy-2-methyl-5-(1-methylethyl)phenyl)-
1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (S-(R*,S*))-
1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, hydrochloride, (S-(R*,S*))-, mixt. with 1-(4-hydroxy-3-methoxyphenyl)-1,2,3-propanetriol
1(3H)-Isobenzofuranone, 6-hydroxy-7-methoxy-
1(3H)-isobenzofuranone, 7-hydroxy-6-methoxy-
1(4H)-Naphthalenone, 2-amino-4-imino-
1(4H)-Pyridineacetic acid, 3,5-diiodo-4-oxo-, compd. with 2,2'-iminobis(ethanol) (1:1)
1(4H)-Pyridineacetic acid, 3,5-diiodo-4-oxo-, propyl ester
1(4H)-Pyridinepropanoic acid, alpha-amino-3-hydroxy-4-oxo-, (S)-
1(4H)-Quinolinepropanesulfonic acid, 4-(4-(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)-2-butenylidene)-, sodium salt
1(5H)-Phenazinone, 5-(5-(2,2-dimethyl-6-methylenecyclohexyl)-3-methyl-2-pentenyl)-, (-)-
1(5H)-Phenazinone, 5-methyl-
1(6H)-Pyridazinebutanoic acid, 3-(4-chlorophenyl)-6-imino-, monohydrochloride
1(6H)-Pyridazinebutanoic acid, 6-imino-3-(4-methoxyphenyl)-, monohydrobromide
1(6H)-Pyridazinebutanoic acid, 6-imino-5-methyl-3-phenyl-, monohydrochloride
1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
1(R)-coclaurine
1(S),3(R)-dihydroxy-20(R)-(4-hydroxy-4-trifluoromethyl-5,5-5-trif-luoro-1-pent-2-ynyloxymethyl)-9,10-sero-pregna-5(Z),7(E),10(19)-triene-alpha,25(OH)2D3
1(S),3(R)-dihydroxy-20(R)-(5'-ethyl-5'-hydroxyhepta-1'(E),3'(E)-dien-1'-yl)-9,10-secopregna-5(Z),7(E),10(19)-triene
1(S)-norcoclaurine